CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-10 | Anicetti Vincent R Chief Operating Officer | Shares withheld for taxes | −4,080 | $18.18 | $74K | 28,489 |
| 2021-01-05 | STOLPER MARK Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2021-01-05 | MENDELSON ALAN C Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2020-12-17 | Anicetti Vincent R Chief Operating Officer | Option exercise | +2,500 | $2.50 | $6K | 35,069 |
| 2020-12-17 | Anicetti Vincent R Chief Operating Officer | Sale | −2,500 | $17.51 | $44K | 32,569 |
| 2020-12-17 | Anicetti Vincent R Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −2,500 | 4,988 | ||
| 2020-12-10 | Vexler Vladimir Chief Scientific Officer | Option exercise | +17,626 | $2.08 | $37K | 54,299 |
| 2020-12-10 | Vexler Vladimir Chief Scientific Officer | Sale | −17,626 | $18.05 | $318K | 36,673 |
| 2020-12-10 | Vexler Vladimir Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −17,626 | 24,356 | ||
| 2020-12-09 | Vexler Vladimir Chief Scientific Officer | Option exercise | +30,000 | $2.08 | $63K | 86,185 |
| 2020-12-09 | Vexler Vladimir Chief Scientific Officer | Sale | −49,512 | $18.24 | $903K | 36,673 |
| 2020-12-09 | Vexler Vladimir Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −30,000 | 41,982 | ||
| 2020-12-07 | Anicetti Vincent R Chief Operating Officer | Option exercise | +3,000 | $12.37 | $37K | 35,569 |
| 2020-12-07 | Anicetti Vincent R Chief Operating Officer | Option exercise | +5,791 | $12.70 | $74K | 41,360 |
| 2020-12-07 | Anicetti Vincent R Chief Operating Officer | Sale | −8,791 | $18.42 | $162K | 32,569 |
| 2020-12-07 | Anicetti Vincent R Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −3,000 | 123,000 | ||
| 2020-12-07 | Anicetti Vincent R Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −5,791 | 0 | ||
| 2020-12-04 | Anicetti Vincent R Chief Operating Officer | Option exercise | +32,291 | $16.75 | $541K | 64,860 |
| 2020-12-04 | Anicetti Vincent R Chief Operating Officer | Option exercise | +16,709 | $12.70 | $212K | 81,569 |
| 2020-12-04 | Anicetti Vincent R Chief Operating Officer | Sale | −49,000 | $18.85 | $924K | 32,569 |
Page 12 of 39 · 768 trades